ExLibris header image
SFX Logo
Title: Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies
Source:

Science Advances [2375-2548] Lu, L yr:2019


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "High-Throughput Assay to Screen Small Molecules for Their Ability to Prevent Sickling of Red Blood Cells." ACS omega. 7.16: 14009-14016. Link to SFX for this item
2. "Recent Advances in the Treatment of Sickle Cell Disease." Frontiers in physiology. 11: 435-435. Link to SFX for this item
3. "Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease." Molecules : a journal of synthetic chemistry and natural product chemistry. 24.24: 4551-. Link to SFX for this item
4. Brugnara, C. "Sickle cell dehydration: Pathophysiology and therapeutic applications." Clinical Hemorheology and Microcirculation 68.2-3 (2018): 187-204. Link to SFX for this item
5. Martinelli, G. "Nilotinib: A novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance." Biologics 1.2 (2007): 121-127. Link to Full Text for this item Link to SFX for this item
6. Swe KMM, Kye Mon Min M. "Zinc supplements for treating thalassaemia and sickle cell disease." Cochrane Database of Systematic Reviews 6.6 (2013). Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.